Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04536233
Other study ID # CHIN-PLAGH-MP-05
Secondary ID
Status Not yet recruiting
Phase Phase 1
First received
Last updated
Start date October 10, 2020
Est. completion date March 30, 2021

Study information

Verified date September 2020
Source Chinese PLA General Hospital
Contact Meirong Li, doctor
Phone 010-66936345
Email meirong811225@126.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Nasal trauma, deviated nasal septum, sinusitis, nasal polyps and other nasal benign diseases are common clinical diseases and require endoscopic sinus surgery. The proper application of the surgical procedure as well as ensuring high quality of wound healing, is also important to achieve successful results in endoscopic sinus surgery. If good quality wound healing cannot be achieved in the surgical field,synechiae and anatomic defects can occur that may require revision surgeries.

Mesenchymal stem cells play an active role in the treatment of many diseases. it primarily exerts therapeutic effects through paracrine. In this study, the effect of mesenchymal stem cell-derived multipotent factors on mucosal repair after nasal surgery was evaluated.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 50
Est. completion date March 30, 2021
Est. primary completion date January 31, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria:

1. 18 to 60 years old;

2. The clinical diagnosis is nasal trauma, nasal septum deviation, sinusitis, and nasal polyps requiring endoscopic surgery;

3. The patient's physical and mental state is stable, and he can return to the hospital regularly for follow-up examinations and cooperate to complete the experiment;

Exclusion Criteria:

1. Younger than 18 or older than 60;

2. Clinical diagnosis of nasal malignancies, or uncontrolled severe infectious diseases;

3. Past medical history of mental illness, malignant tumor, nose surgery;

4. People with serious underlying diseases (hypertension, diabetes, rheumatism, asthma) require long-term medication;

5. Long-term smoking, more than 5 cigarettes per day;

6. Work or daily life environment is exposed to large amounts of dust and chemical raw materials;

Study Design


Related Conditions & MeSH terms


Intervention

Biological:
MSCs Derived Pleiotropic Factors
The pleiotropic factor derived from mesenchymal stem cells was injected on the wound
Other:
physiological saline
The physiological saline was injected on the wound

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Chinese PLA General Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary Wound healing evaluation Lund-Kennedy scoring method;under video nasal endoscopy. Including five aspects of polyps, edema, rhinorrhea, scars, and scabs, each score is 0-2 points. Polyp: 0 points means no polyps, 1 point means polyps only in the middle nasal passage, 2 points means polyps beyond the middle nasal passage. Edema: 0 points means no edema, 1 point means mild edema, 2 points means severe edema. Rhinorrhea: 0 points means no rhinorrhea, 1 point means clear and thin nose, 2 points means rhinorrhea is sticky and purulent. Scar: 0 points means no scars, 1 points means mild scars, 2 points means severe scars. Scab formation: 0 points means no scab formation, 1 point means mild scab formation, and 2 points means severe scab formation. Each side 0-10 points, a total of 20 points, the lower the score indicates that the patient's symptoms are lighter. 2 months